ExLibris header image
SFX Logo
Title: Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Law, Amanda yr:2012


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Borrelli, E. "Structure and function of dopamine receptors." Neuroscience and biobehavioral reviews 24.1 (1999): 125-32. Link to Full Text for this item Link to SFX for this item
2. Wen, L. "Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons." Proceedings of the National Academy of Sciences of the United States of America 107.3 (2009): 1211-1216. Link to Full Text for this item Link to SFX for this item
3. Owen JC, Jenny C. E S. "Chronic treatment with antidepressant drugs reversibly alters NMDA mediated regulation of extracellular 5-HT in rat frontal cortex." Brain Research Bulletin 70.1 (2006): 62-67. Link to SFX for this item
4. Tanzi, Rudolph E E. "Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database." Nature genetics 39.1 (2007): 17-23. Link to Full Text for this item Link to SFX for this item
5. Hahn, Chang-Gyu G. "Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia." Nature medicine 12.7 (2006): 824-8. Link to Full Text for this item Link to SFX for this item
6. Bertram, L. "Genetic research in schizophrenia: New tools and future perspectives." Schizophrenia Bulletin 34.5 (2008): 806-812. Link to Full Text for this item Link to SFX for this item
7. Jaber, M. "Dopamine receptors and brain function." Neuropharmacology 35.11 (1996): 1503-19. Link to Full Text for this item Link to SFX for this item
8. McCarroll, Aswin E. "Schizophrenia risk from complex variation of complement component 4." Nature 530.7589 (2016): 177-83. Link to Full Text for this item Link to SFX for this item
9. Tiwari, Arun K. "Genetics in schizophrenia: where are we and what next?" Dialogues in clinical neuroscience 12.3 (2010): 289-303. Link to Full Text for this item Link to SFX for this item
10. Jackson, M. "Dopamine receptors: molecular biology, biochemistry and behavioural aspects." Pharmacology & therapeutics 64.2 (1994): 291-370. Link to Full Text for this item Link to SFX for this item
11. Dodson, Sara E E. "LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease." Journal of neuropathology and experimental neurology 65.9 (2006): 866-872. Link to SFX for this item
12. Harrison, Paul J. "Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology." Biological Psychiatry 60.2 (2006): 132-40. Link to SFX for this item
13. Missale, C. "Dopamine receptors: from structure to function." Physiological reviews 78.1 (1997): 189-225. Link to SFX for this item
14. Liu, X. "Specific regulation of NRG1 isoform expression by neuronal activity." The Journal of neuroscience 31.23 (2011): 8491-501. Link to Full Text for this item Link to SFX for this item
15. Chen, Y. "ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation." Proceedings of the National Academy of Sciences of the United States of America 107.50 (2010): 21818-21823. Link to Full Text for this item Link to SFX for this item
16. Pirrotta, V. "It's Not Just Sex." Developmental cell 19.3 (2010): 359-360. Link to SFX for this item
17. Birgner, C. "VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation." Proceedings of the National Academy of Sciences of the United States of America 107.1 (2010): 389-394. Link to Full Text for this item Link to SFX for this item
18. White, Kellie J J. "Serotonin transporters: implications for antidepressant drug development." The AAPS journal 7.2 (2005): 421-33. Link to Full Text for this item Link to SFX for this item
19. ZALEWSKAKASZUBSKA, J. "Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference." Neuroscience Letters 431.3 (2008): 221-225. Link to SFX for this item
20. Segieth J, J. "Regulatory role of nitric oxide over hippocampal 5-HT release in vivo." Naunyn-Schmiedeberg's archives of pharmacology 363.3 (2001): 302-306. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced